Literature DB >> 19640004

Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach.

Hui Li1, Xiao-Peng Xiong, Bo Peng, Chang-Xin Xu, Ming-Zhi Ye, Tian-Ci Yang, San-Ying Wang, Xuan-Xian Peng.   

Abstract

Bacterium is still one of the major causes of life-threatening microbial infections. The most effective way to control bacterial infections is probably vaccine prevention. However, development of bacterial vaccine, especially polyvalent vaccines that could be used to fight against a variety of bacterial serotypes and species, is challenging due to the difficulty in identifying broad cross-protective antigens for different serotypes and species of pathogenic bacteria. In the present study, we developed a new approach to identify polyvalent vaccine candidates from outer membrane (OM) proteins of Vibrio alginolyticus with the ability to fight against infections caused by different genera and families of Gram-negative bacteria. This approach combined heterogeneous antiserum-based immunoproteomics with bacterial immunization challenging method. Four of the 35 protein spots resolved in a 2-DE gel of V. alginolyticus sarcosine-insoluble fraction could be recognized not only by homogeneous antiserum, but also by heterogeneous antisera obtained from other bacterial species, genera and families. The genes encoding the four OM proteins were then cloned and expressed in E. coli BL21. The expressed recombinant proteins were used as broadly cross-protective immunogens to immunize carps for investigation of their cross-protective spectra, activities and protective abilities in carps. The carps immunized with OmpA (VA0764) and Pal (VA1061) have abilities to fight against infections not only caused by V. alginolyticus, but also by Aeromonas hydrophila and Pseudomonas fluorescens. This study provides a novel approach for the identification of broadly cross-protective antigens, and possibly polyvalent vaccines against a variety of microbial infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640004     DOI: 10.1021/pr900439j

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.

Authors:  Debasis Pore; Nibedita Mahata; Amit Pal; Manoj K Chakrabarti
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

2.  Screening diagnostic candidates for schistosomiasis from tegument proteins of adult Schistosoma japonicum using an immunoproteomic approach.

Authors:  Min Zhang; Zhiqiang Fu; Changjian Li; Yanhui Han; Xiaodan Cao; Hongxiao Han; Yantao Liu; Ke Lu; Yang Hong; Jiaojiao Lin
Journal:  PLoS Negl Trop Dis       Date:  2015-02-23

3.  TolC plays a crucial role in immune protection conferred by Edwardsiella tarda whole-cell vaccines.

Authors:  Chao Wang; Bo Peng; Hui Li; Xuan-Xian Peng
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

4.  Comparative bioinformatic and proteomic approaches to evaluate the outer membrane proteome of the fish pathogen Yersinia ruckeri.

Authors:  Michael J Ormsby; Edward Grahame; Richard Burchmore; Robert L Davies
Journal:  J Proteomics       Date:  2019-03-01       Impact factor: 4.044

5.  Identification of Vibrio parahaemolyticus and Vibrio spp. Specific Outer Membrane Proteins by Reverse Vaccinology and Surface Proteome.

Authors:  Wenbin Wang; Jianxin Liu; Shanshan Guo; Lei Liu; Qianyun Yuan; Lei Guo; Saikun Pan
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

6.  Identification of Polyvalent Vaccine Candidates From Extracellular Secretory Proteins in Vibrio alginolyticus.

Authors:  Yu-Ming Peng; Jian-Jun Tao; Su-Fang Kuang; Ming Jiang; Xuan-Xian Peng; Hui Li
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

7.  Expression of LamB Vaccine Antigen in Wolffia globosa (Duck Weed) Against Fish Vibriosis.

Authors:  P P M Heenatigala; Zuoliang Sun; Jingjing Yang; Xuyao Zhao; Hongwei Hou
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.